Laura Damme, VP, Clinical Affairs at TransMedics Group, Inc. (TMDX), sold 21,624 shares at $62.43 ($1.3M) on 2022-12-14, disclosed to the SEC on 2022-12-16.
Open-market sale of $1.3M TMDX by VP, Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.43 | 5,947 | $371K | 28.2% |
| 2 | $62.43 | 5,947 | $371K | 28.2% |
| 3 | $58.96 | 4,740 | $279K | 21.2% |
| 4 | $58.96 | 4,740 | $279K | 21.2% |
| 5 | $60.02 | 250 | $15K | 1.1% |
| Total | $60.88 avg | 21,624 |
| $1.3M |
| 100% |